Facultad de Ciencia y Tecnología
Centro
Pitié-Salpêtrière Hospital
París, FranciaPublicaciones en colaboración con investigadoras/es de Pitié-Salpêtrière Hospital (12)
2021
-
Aptamarker prediction of brain amyloid-β status in cognitively normal individuals at risk for Alzheimer’s disease
PLoS ONE, Vol. 16, Núm. 1 January
-
Future avenues for Alzheimer's disease detection and therapy: liquid biopsy, intracellular signaling modulation, systems pharmacology drug discovery
Neuropharmacology, Vol. 185
-
Lipoprotein metabolism in familial hypercholesterolemia
Journal of Lipid Research, Vol. 62
-
MiRNA-15b and miRNA-125b are associated with regional Aβ-PET and FDG-PET uptake in cognitively normal individuals with subjective memory complaints
Translational Psychiatry, Vol. 11, Núm. 1
2020
-
Age and sex impact plasma NFL and t-Tau trajectories in individuals with subjective memory complaints: a 3-year follow-up study
Alzheimer's Research and Therapy, Vol. 12, Núm. 1
-
Association of plasma YKL-40 with brain amyloid-β levels, memory performance, and sex in subjective memory complainers
Neurobiology of Aging, Vol. 96, pp. 22-32
-
Successful aging: Insights from proteome analyses of healthy centenarians
Aging, Vol. 12, Núm. 4, pp. 3502-3515
-
β-Secretase1 biological markers for Alzheimer’s disease: state-of-art of validation and qualification
Alzheimer's Research and Therapy, Vol. 12, Núm. 1
2015
-
Genome-wide significant association with seven novel multiple sclerosis risk loci
Journal of Medical Genetics, Vol. 52, Núm. 12, pp. 848-855
2013
-
Genome-wide significant association of ANKRD55 rs6859219 and multiple sclerosis risk
Journal of Medical Genetics, Vol. 50, Núm. 3, pp. 140-143
-
MANBA, CXCR5, SOX8, RPS6KB1 and ZBTB46 are genetic risk loci for multiple sclerosis
Brain, Vol. 136, Núm. 6, pp. 1778-1782
2012
-
Closing the case of APOE in multiple sclerosis: No association with disease risk in over 29 000 subjects
Journal of Medical Genetics, Vol. 49, Núm. 9, pp. 558-562